Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Aaron Winn PhD

Aaron Winn PhD

Assistant Professor

Institution: Medical College of Wisconsin
Department: School of Pharmacy
Division: Administration
Program: Program Development

Member of the Cancer Center


Publications

  • Quantifying downstream impact of inappropriate staging imaging in a cohort of veterans with low- and intermediate-risk incident prostate cancer. (Drangsholt S, Walter D, Ciprut S, Lepor A, Sedlander E, Curnyn C, Loeb S, Malloy P, Winn AN, Makarov DV) Urol Oncol 2019 Feb;37(2):145-149 PMID: 30578160 12/24/2018    
  • More evidence on the limited impact of state oral oncology parity laws. (Winn AN, Dusetzina SB) Cancer 2018 Dec 19 PMID: 30566761 12/20/2018    
  • Using Group-based Trajectory Models and Propensity Score Weighting to Detect Heterogeneous Treatment Effects: The Case Study of Generic Hormonal Therapy for Women With Breast Cancer. (Winn AN, Fergestrom NM, Neuner JM) Med Care 2019 Jan;57(1):85-93 PMID: 30489546 PMCID: PMC6291347 11/30/2018    
  • Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial. (Wan W, Skandari MR, Minc A, Nathan AG, Zarei P, Winn AN, O'Grady M, Huang ES) Med Decis Making 2018 Nov;38(8):942-953 PMID: 30403576 PMCID: PMC6226055 11/08/2018    
  • Making Sure We Don't Forget the Basics When Using Machine Learning. (Winn AN, Neuner JM) J Natl Cancer Inst 2018 Oct 21 PMID: 30346555 10/23/2018    
  • Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial. (Wan W, Skandari MR, Minc A, Nathan AG, Winn A, Zarei P, O'Grady M, Huang ES) Diabetes Care 2018 06;41(6):1227-1234 PMID: 29650803 PMCID: PMC5961392 04/14/2018       5 Citations
  • Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries. (Mitchell AP, Winn AN, Dusetzina SB) JAMA Intern Med 2018 Jun 01;178(6):854-856 PMID: 29630687 PMCID: PMC6145757 04/10/2018    
  • Spending by Commercial Insurers on Chemotherapy Based on Site of Care, 2004-2014. (Winn AN, Keating NL, Trogdon JG, Basch EM, Dusetzina SB) JAMA Oncol 2018 Apr 01;4(4):580-581 PMID: 29470578 PMCID: PMC5885220 02/23/2018    
  • Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis. (Laiteerapong N, Cooper JM, Skandari MR, Clarke PM, Winn AN, Naylor RN, Huang ES) Ann Intern Med 2018 02 06;168(3):170-178 PMID: 29230472 PMCID: PMC5989575 12/13/2017       2 Citations
  • Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws. (Dusetzina SB, Huskamp HA, Winn AN, Basch E, Keating NL) JAMA Oncol 2018 Jun 14;4(6):e173598 PMID: 29121177 PMCID: PMC6054307 11/10/2017       3 Citations
  • Endocrine Therapy Initiation among Older Women with Ductal Carcinoma In Situ. (Anderson C, Winn AN, Dusetzina SB, Nichols HB) J Cancer Epidemiol 2017;2017:6091709 PMID: 29056966 PMCID: PMC5615957 10/24/2017    
  • Supplemental Nutrition Assistance Program (SNAP) Benefit Cycles and Student Disciplinary Infractions (Gennetian, L, Seshadri, R, Hess, N, Winn, AN, Goerge, R) Social Service Review 90(3): 403-433. 08/25/2017    
  • Reply to E. Ritchie et al. (Winn AN, Keating NL, Dusetzina SB) J Clin Oncol 2017 May 20;35(15):1745-1746 PMID: 28524775 05/20/2017    
  • The Role of the FDA and Regulatory Approval of New Devices for Diabetes Care. (Jazowski SA, Winn AN) Curr Diab Rep 2017 06;17(6):40 PMID: 28439847 04/26/2017       2 Citations
  • Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis. (Chou YT, Winn AN, Rosenstein DL, Dusetzina SB) Pharmacoepidemiol Drug Saf 2017 Jun;26(6):676-684 PMID: 28317314 PMCID: PMC5457339 03/21/2017       1 Citations
  • Untangling the Black-White mortality gap in endometrial cancer: a cohort simulation. (Doll KM, Winn AN, Goff BA) Am J Obstet Gynecol 2017 03;216(3):324-325 PMID: 28034650 12/31/2016       4 Citations
  • Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia. (Winn AN, Keating NL, Dusetzina SB) J Clin Oncol 2016 12 20;34(36):4323-4328 PMID: 27998234 PMCID: PMC5455309 12/22/2016       30 Citations
  • Association between timing of cervical excision procedure to minimally invasive hysterectomy and surgical complications. (Sullivan SA, Clark LH, Staley AS, Tran AQ, Winn A, Kim KH) Gynecol Oncol 2017 Feb;144(2):294-298 PMID: 27894753 11/30/2016    
  • Cost Implications of Comorbidity for Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma Using SEER-Medicare. (Shah GL, Winn A, Lin PJ, Klein A, Sprague KA, Smith HP, Buchsbaum R, Cohen JT, Miller KB, Comenzo R, Parsons SK) Bone Marrow Res 2016;2016:3645623 PMID: 27830092 PMCID: PMC5088316 11/11/2016    
  • Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter? (Aarnio E, Martikainen J, Winn AN, Huupponen R, Vahtera J, Korhonen MJ) Circ Cardiovasc Qual Outcomes 2016 11;9(6):704-713 PMID: 27756795 10/21/2016       3 Citations
  • The association between trajectories of endocrine therapy adherence and mortality among women with breast cancer. (Winn AN, Dusetzina SB) Pharmacoepidemiol Drug Saf 2016 08;25(8):953-9 PMID: 27125337 04/30/2016       3 Citations
  • Linking Costs and Survival in the Treatment of Older Adults With Chronic Myeloid Leukemia: An Analysis of SEER-Medicare Data From 1995 to 2007. (Lin PJ, Winn AN, Parsons SK, Neumann PJ, Weiss ES, Cohen JT) Med Care 2016 Apr;54(4):380-5 PMID: 26759984 01/14/2016       4 Citations
  • Cost-Utility Analysis of Cancer Prevention, Treatment, and Control: A Systematic Review. (Winn AN, Ekwueme DU, Guy GP Jr, Neumann PJ) Am J Prev Med 2016 Feb;50(2):241-8 PMID: 26470806 PMCID: PMC5846573 10/17/2015       6 Citations
  • How Do Payers Respond to Regulatory Actions? The Case of Bevacizumab. (Dusetzina SB, Ellis S, Freedman RA, Conti RM, Winn AN, Chambers JD, Alexander GC, Huskamp HA, Keating NL) J Oncol Pract 2015 Jul;11(4):313-8 PMID: 26060224 PMCID: PMC4507391 06/11/2015       1 Citations
  • Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results-Medicare Database. (Shah GL, Winn AN, Lin PJ, Klein A, Sprague KA, Smith HP, Buchsbaum R, Cohen JT, Miller KB, Comenzo R, Parsons SK) Biol Blood Marrow Transplant 2015 Oct;21(10):1823-9 PMID: 26033281 PMCID: PMC4933291 06/03/2015       14 Citations
  • The real world effectiveness of hematopoietic transplant among elderly individuals with multiple myeloma. (Winn AN, Shah GL, Cohen JT, Lin PJ, Parsons SK) J Natl Cancer Inst 2015 Aug;107(8) PMID: 26023094 PMCID: PMC4554189 05/30/2015       13 Citations
  • An assessment of the methodological quality of published network meta-analyses: a systematic review. (Chambers JD, Naci H, Wouters OJ, Pyo J, Gunjal S, Kennedy IR, Hoey MG, Winn A, Neumann PJ) PLoS One 2015;10(4):e0121715 PMID: 25923737 PMCID: PMC4414531 04/30/2015       13 Citations
  • Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences. (Lin PJ, Kent DM, Winn A, Cohen JT, Neumann PJ) Am J Manag Care 2015 Jan 01;21(1):e23-34 PMID: 25880265 04/17/2015       29 Citations
  • Cost-utility analyses in diabetes: a systematic review and implications from real-world evidence. (Zhong Y, Lin PJ, Cohen JT, Winn AN, Neumann PJ) Value Health 2015 Mar;18(2):308-14 PMID: 25773567 03/17/2015       12 Citations
  • Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses. (Saret CJ, Winn AN, Shah G, Parsons SK, Lin PJ, Cohen JT, Neumann PJ) Blood 2015 Mar 19;125(12):1866-9 PMID: 25655601 PMCID: PMC4366623 02/07/2015       25 Citations
  • Potential role of network meta-analysis in value-based insurance design. (Chambers JD, Winn A, Zhong Y, Olchanski N, Cangelosi MJ) Am J Manag Care 2014 Aug;20(8):641-8 PMID: 25295678 10/09/2014    
  • Abdominal aortic aneurysm screening: how many life years lost from underuse of the medicare screening benefit? (Olchanski N, Winn A, Cohen JT, Neumann PJ) J Gen Intern Med 2014 Aug;29(8):1155-61 PMID: 24715406 PMCID: PMC4099445 04/10/2014       8 Citations
  • Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. (Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL) J Clin Oncol 2014 Feb 01;32(4):306-11 PMID: 24366936 12/25/2013       177 Citations
  • Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications. (Naylor RN, John PM, Winn AN, Carmody D, Greeley SA, Philipson LH, Bell GI, Huang ES) Diabetes Care 2014;37(1):202-9 PMID: 24026547 PMCID: PMC3867988 09/13/2013       46 Citations
  • Substantial Medicare savings may result if insurers cover 'artificial pancreas' sooner for diabetes patients. (O'Grady MJ, John P, Winn A) Health Aff (Millwood) 2012 Aug;31(8):1822-9 PMID: 22869661 08/08/2012       1 Citations
  • Health utilities for children and adults with type 1 diabetes. (Lee JM, Rhee K, O'grady MJ, Basu A, Winn A, John P, Meltzer DO, Kollman C, Laffel LM, Lawrence JM, Tamborlane WV, Wysocki T, Xing D, Huang ES, JDRF Continuous Glucose Monitoring Study Group) Med Care 2011 Oct;49(10):924-31 PMID: 21544001 PMCID: PMC3210197 05/06/2011       15 Citations
  • The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes. (Greeley SA, John PM, Winn AN, Ornelas J, Lipton RB, Philipson LH, Bell GI, Huang ES) Diabetes Care 2011 Mar;34(3):622-7 PMID: 21273495 PMCID: PMC3041194 01/29/2011       45 Citations
  • The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. (Huang ES, O'Grady M, Basu A, Winn A, John P, Lee J, Meltzer D, Kollman C, Laffel L, Tamborlane W, Weinzimer S, Wysocki T, Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group) Diabetes Care 2010 Jun;33(6):1269-74 PMID: 20332354 PMCID: PMC2875436 03/25/2010       72 Citations
  • Last update: 01/18/2019
    jenkins-FCD Prod-300 626508253d14e4184314fb9f66322a03a5906796